Showing 1 - 20 results of 30 for search 'Hisashi Yamanaka', query time: 0.06s Refine Results
  1. 1
    Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis

    Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis by Akiko Tochimoto, Yasushi Kawaguchi, Hisashi Yamanaka

    Published 2016-03-01
    Get full text
    Article
  2. 2
    Interstitial Lung Disease with ANCA-associated Vasculitis

    Interstitial Lung Disease with ANCA-associated Vasculitis by Yasuhiro Katsumata, Yasushi Kawaguchi, Hisashi Yamanaka

    Published 2015-01-01
    Get full text
    Article
  3. 3
    Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies

    Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies by Hidenaga Kawasumi, Takahisa Gono, Yasushi Kawaguchi, Hisashi Yamanaka

    Published 2015-01-01
    Get full text
    Article
  4. 4
    Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies

    Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies by Hidenaga Kawasumi, Takahisa Gono, Yasushi Kawaguchi, Hisashi Yamanaka

    Published 2015-07-01
    Get full text
    Article
  5. 5
    A case of psoriatic arthritis, with joint involvement preceding skin involvement, successfully treated with adalimumab (80 mg every other week)

    A case of psoriatic arthritis, with joint involvement preceding skin involvement, successfully treated with adalimumab (80 mg every other week) by Yuki Nanke, Tsuyoshi Kobashigawa, Naoki Sugimoto, Hisashi Yamanaka, Shigeru Kotake

    Published 2019-04-01
    Get full text
    Article
  6. 6
    Pneumatosis Intestinalis Associated with Juvenile Dermatomyositis

    Pneumatosis Intestinalis Associated with Juvenile Dermatomyositis by Takako Miyamae, Naoko Ishiguro, Maria Yonezawa, Katsutoshi Tokushige, Hisashi Yamanaka

    Published 2016-01-01
    Get full text
    Article
  7. 7
    Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody

    Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody by Takako Miyamae, Takuma Hara, Aki Hanaya, Yumi Tani, Takayuki Kishi, Hisashi Yamanaka

    Published 2018-01-01
    Get full text
    Article
  8. 8
    Regional overdistension during prone positioning in a patient with acute respiratory failure who was ventilated with a low tidal volume: a case report

    Regional overdistension during prone positioning in a patient with acute respiratory failure who was ventilated with a low tidal volume: a case report by Toru Kotani, Masanori Hanaoka, Shinya Hirahara, Hisashi Yamanaka, Eckhard Teschner, Atsuko Shono

    Published 2018-03-01
    Get full text
    Article
  9. 9
    Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet’s Disease

    Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet’s Disease by Mariko Kaji, Takayuki Kishi, Takako Miyamae, Satoru Nagata, Hisashi Yamanaka, Satoshi Fujikawa

    Published 2015-01-01
    Get full text
    Article
  10. 10
    A Case of Human Leukocyte Antigen (HLA) B27-Positive Intestinal Behçet's Disease with Crohn's Disease-Like Anal Fistulas

    A Case of Human Leukocyte Antigen (HLA) B27-Positive Intestinal Behçet's Disease with Crohn's Disease-Like Anal Fistulas by Tsuyoshi Kobashigawa, Yuki Nanke, Masakazu Takazoe, Kuniko Iihara, Hisashi Yamanaka, Shigeru Kotake

    Published 2014-01-01
    Get full text
    Article
  11. 11
    An osteoprotegerin gene polymorphism is associated with an increased risk of hip fracture in Japanese patients with rheumatoid arthritis: results from the IORRA Observational Cohort Study.

    An osteoprotegerin gene polymorphism is associated with an increased risk of hip fracture in Japanese patients with rheumatoid arthritis: results from the IORRA Observational Cohor... by Shinji Yoshida, Katsunori Ikari, Takefumi Furuya, Yoshiaki Toyama, Atsuo Taniguchi, Hisashi Yamanaka, Shigeki Momohara

    Published 2014-01-01
    Get full text
    Article
  12. 12
    Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database

    Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database by Masataka Honda, Hideki Horiuchi, Tomoko Torii, Akihiro Nakajima, Takeshi Iijima, Hiroshi Murano, Hisashi Yamanaka, Shuichi Ito

    Published 2021-12-01
    Get full text
    Article
  13. 13
    Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database

    Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database by Shuichi Ito, Tomoko Torii, Akihiro Nakajima, Takeshi Iijima, Hiroshi Murano, Hideki Horiuchi, Hisashi Yamanaka, Masataka Honda

    Published 2020-10-01
    Get full text
    Article
  14. 14
    Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry

    Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from t... by Masayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, Ryoko Sakai, Naohiro Sugitani, Shigeyuki Toyoizumi, Naonobu Sugiyama, Hisashi Yamanaka

    Published 2024-07-01
    Get full text
    Article
  15. 15
    Functional Analysis of Human Sodium-Phosphate Transporter 4 (NPT4/SLC17A3) Polymorphisms

    Functional Analysis of Human Sodium-Phosphate Transporter 4 (NPT4/SLC17A3) Polymorphisms by Promsuk Jutabha, Naohiko Anzai, Toru Kimura, Atsuo Taniguchi, Wako Urano, Hisashi Yamanaka, Hitoshi Endou, Hiroyuki Sakurai

    Published 2011-01-01
    Get full text
    Article
  16. 16
    Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients

    Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients by Tsutomu Takeuchi, Hisashi Yamanaka, Masayoshi Harigai, Ryo Tamamura, Yuichi Kato, Yoshifumi Ukyo, Toshikazu Nakano, Benjamin Hsu, Yoshiya Tanaka

    Published 2018-03-01
    Get full text
    Article
  17. 17
    Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies

    Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies by Mark C. Genovese, Patrick Durez, Roy Fleischmann, Yoshiya Tanaka, Daniel Furst, Hisashi Yamanaka, Elena Korneva, Igor Vasyutin, Tsutomu Takeuchi

    Published 2021-07-01
    Get full text
    Article
  18. 18
    Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment

    Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment by Tomoaki Higuchi, Kae Takagi, Akiko Tochimoto, Yuki Ichimura, Takanari Norose, Yasuhiro Katsumata, Ikuko Masuda, Hisashi Yamanaka, Toshiro Morohoshi, Yasushi Kawaguchi

    Published 2019-04-01
    Get full text
    Article
  19. 19
    Features of patients with rheumatoid arthritis whose debut joint is a foot or ankle joint: A 5,479-case study from the IORRA cohort.

    Features of patients with rheumatoid arthritis whose debut joint is a foot or ankle joint: A 5,479-case study from the IORRA cohort. by Koichiro Yano, Katsunori Ikari, Eisuke Inoue, Yu Sakuma, Takeshi Mochizuki, Naoko Koenuma, Haruki Tobimatsu, Eiichi Tanaka, Atsuo Taniguchi, Ken Okazaki, Hisashi Yamanaka

    Published 2018-01-01
    Get full text
    Article
  20. 20
    A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis

    A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis by Hisashi Yamanaka, Naoyuki Kamatani, Yoshiya Tanaka, Toshihiko Hibino, Edit Drescher, Juan Sánchez-Bursón, Manfred Rettenbacher, Girish Bhatia, Snehal Gadve, Chirag Shah, Dhananjay Bakhle

    Published 2019-12-01
    Get full text
    Article

Search Tools: